Mona P Feng, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 60 Exeter Rd., Bldg. 100. Ste 103, Newmarket, NH 03857 Phone: 603-659-1600 Fax: 603-659-6767 |
Sarah Oxnard, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 207 S Main St, Newmarket, NH 03857 Phone: 603-659-3106 Fax: 603-659-8003 |
News Archive
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that fuels prostate-cancer growth - via surgical castration (orchiectomy) or medical castration with testosterone-blocking drugs. While such therapy buys time for patients, it is not a cure, as inevitably the cancer becomes resistant to the androgen deprivation and continues to grow.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the results from a preclinical study showing in vitro and in vivo activity of its first-in-class PRMT5 inhibitor EPZ015666 in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin lymphoma (NHL).
Three Johns Hopkins University School of Medicine researchers have been awarded two-year grants for their work on potential treatments for diabetes, Novo Nordisk announced this month. Of the 110 initial submissions to the new Novo Nordisk Diabetes and Obesity Biologics Science Forum Program, only four projects were funded, three of which are led by Johns Hopkins researchers. They are Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, M.D., Ph.D.
Certain symptoms associated with the development of Alzheimer's disease, including agitation and depression, affect Hispanics more frequently and severely than other ethnicities.
› Verified 1 days ago